As India hosts the Artificial
Intelligence (AI) Impact Summit from February 16 to 20, 2026,
artificial intelligence has moved from futuristic ambition to present-day
reality. Policymakers, technology leaders, hospital administrators, and
startups are gathering to discuss scale, innovation, and deployment across
sectors — with healthcare positioned as one of the most transformative
frontiers.
AI-enabled imaging, predictive dashboards, automated stroke
alerts, and decision-support systems are increasingly being showcased as
evidence of rapid digital advancement. The promise is powerful: faster
diagnosis, earlier intervention, improved outcomes, and smarter resource
allocation.
Yet as the country celebrates progress, an important public health
question demands equal attention: Is artificial intelligence strengthening healthcare
equity — or quietly widening the gap between those who can access digital
augmentation and those who cannot?
While advanced AI systems will operate
in select tertiary centers and corporate hospitals, many district facilities
continue to rely on manual workflows and limited specialist support. The
disparity is not in disease burden. It is in digital access.
India
does not lack Artificial Intelligence in healthcare. What we lack is
integration.
Today,
AI is displayed in select corporate hospitals as a badge of superiority —
AI-enabled imaging, AI stroke alerts, AI predictive dashboards, etc. These are important advances. But when
technology becomes a marketing differentiator rather than a system enabler, it
creates a new divide: digital inequity.
AI
was meant to democratize healthcare. Instead, in its current form, it risks
stratifying it. In one part of the city, a patient benefits from AI-assisted
early stroke detection. In another district hospital, the same patient waits
for a manual report. The difference is not disease severity — it is access to
digital augmentation.
This
is not a technology problem. It is a governance problem. When AI remains
vendor-driven and hospital-owned, it becomes fragmented. Each institution
builds its own digital island. Data stays locked. Algorithms are proprietary.
Interoperability is an afterthought. Public health systems are left negotiating
access rather than leading deployment.
If
we are not careful, AI will amplify the very inequalities healthcare struggles
to overcome. Three risks could be anticipated:
•
Clinical disparity: AI-enhanced care concentrated in high-paying sectors.
•
Economic disparity: Technology costs bundled into premium healthcare pricing.
•
Data bias: Models trained on narrow datasets, underrepresenting rural and
underserved populations.
An
AI model that does not represent India cannot serve India. The solution is not
to slow innovation. The solution is to reposition it. AI must transition from
corporate showcase to public health infrastructure.
Core
AI applications — stroke triage, TB detection, maternal risk stratification, and emergency decision support should not depend
on a hospital’s balance sheet. They should depend on national policy.
Interoperability
must be mandatory. Closed ecosystems are incompatible with population-scale
health. Public procurement models should focus on outcomes — reduced
door-to-needle time, improved detection rates, decreased mortality — not on
algorithmic glamour.
Most
importantly, AI literacy must reach the frontline. Nurses, ASHAs, RMOs, and
district physicians must understand AI outputs — not treat them as
unquestionable authority. Artificial Intelligence must assist clinical
judgment, not replace it.
India
stands at a pivotal moment.
We
can allow AI to become a competitive instrument of institutional branding, or
we can integrate it into a national health grid that strengthens equity. Innovation
without integration is inequity. Technology without governance is
fragmentation. AI without access is exclusion.
If
this AI Impact summit is to be meaningful,
it must shift the conversation from “Who has
AI?” to “Who benefits from AI?”
The
answer should be simple: every patient, every
corner of the country.